Effect of sublingual misoprostol on severe postpartum haemorrhage in a primary health centre in Guinea-Bissau: Randomised double blind clinical trial

British Medical Journal

Volumn 331, Issue 7519, 2005, Pages 723-727

  Høj, Lars ^a   Cardoso, Placido ^b   Nielsen, Birgitte Bruun ^a   Hvidman, Lone ^a   Nielsen, Jens ^c   Aaby, Peter ^c  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b Projecto de Saúde de Bandim ^*  (Guinea-Bissau)

^c DEPARTMENT OF EPIDEMIOLOGY RESEARCH   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

MISOPROSTOL; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG RESPONSE; FEMALE; FEVER; HEALTH CENTER; HEMOGLOBIN DETERMINATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; NAUSEA; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHIVERING; VAGINAL DELIVERY; VOMITING;

ADMINISTRATION, SUBLINGUAL; ADULT; DOUBLE-BLIND METHOD; FEMALE; GUINEA-BISSAU; HUMANS; MISOPROSTOL; OXYTOCICS; POSTPARTUM HEMORRHAGE; PREGNANCY; RISK FACTORS; TABLETS; TREATMENT OUTCOME;

EID: 26244437270     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Rush D. Nutrition and maternal mortality in the developing world. Am J Clin Nutr 2000;72:212S-40S.
2. Brabin BJ, Hakimi M, Pelletier D. An analysis of anemia and pregnancy-related maternal mortality. J Nutr 2001;131:604-6158.
3. Kaestel P. Micronutrient supplementation and other predictors of birth size and perinatal mortality in Guinea-Bissau [thesis]. Copenhagen, Denmark: Department of Epidemiology Research, Statens Serum Institute, 2004.
4. Hoj L, Stensballe J, Aaby P. Maternal mortality in Guinea-Bissau: the use of verbal autopsy in a multi-ethnic population. Int J Epidemiol 1999;28:70-6.
5. Kwast BE. Postpartum haemorrhage: its contribution to maternal mortality. Midwifery 1991;7:64-70.
6. Gulmezoglu AM, Villar J, Ngoc NT, Piaggio G, Carroli G, Adetoro L, et al. WHO multicentre randomised trial of misoprostol in the management of the third stage of labour. Lancet 2001;358:689-95.
7. Maternal and Neonatal Health Program. Preventing postpartum hemorrhage: a community-based approach proves effective in rural Indonesia. Baltimore USA: MNH Program, 2005.
8. Tang OS, Schweer H, Seyberth HW, Lee SW, Ho PC. Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod 2002;17:332-6.
9. Lam H, Tang OS, Lee CP, Ho PC. A pilot-randomized comparison of sublingual misoprostol with syntometrine on the blood loss in third stage of labor. Acta Obstet Gynecol Scand 2004;83:647-50.
10. Prendiville WJ, Elbourne D, McDonald S. Active versus expectant management in the third stage of labour. Cochrane Database Syst Rev 2000;(3):CD000007.
11. Hofmeyr GJ, Nikodem VC, de Jager M, Drakely A. Side-effects of oral misoprostol in the third stage of labour - a randomised placebo-controlled trial. S Afr Med J 2001;91:432-5.
12. Lumbiganon P, Villar J, Piaggio G, Gulmezoglu AM, Adetoro L, Carroli G. Side effects of oral misoprostol during the first 24 hours after administration in the third stage of labour. BJOG 2002;109:1222-6.
13. Bamigboye AA, Hofmeyr GJ, Merrell DA. Rectal misoprostol in the prevention of postpartum hemorrhage: a placebo-controlled trial. Am J Obstet Gynecol 1998;179:1043-6.
14. Hofmeyr GJ, Nikodem VC, de Jager M, Gelbart BR. A randomised placebo controlled trial of oral misoprostol in the third stage of labour. Br J Obstet Gynaecol 1998;105:971-5.
15. Surbek DV, Fehr PM, Hosli I, Holzgreve W. Oral misoprostol for third stage of labor: a randomized placebo-controlled trial. Obstet Gynecol 1999;94:255-8.
16. Prasertcharoensuk W, Swadpanich U, Lumbiganon P. Accuracy of the blood loss estimation in the third stage of labor. Int J Gynaecol Obstet 2000;71:69-70.
17. Hoj L, da Silva D, Hedegaard K, Sandstrom A, Aaby P. Factors associated with maternal mortality in rural Guinea-Bissau. A longitudinal population-based study. BJOG 2002;109:792-9.